De Novo Noninversion Variants Implicated in Sporadic Hemophilia A: A Variant Origin and Timing Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031763 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ming Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, Changhua Christian Hospital, Changhua 500, Taiwan. Hauptthemen laut MEDLINE: Hemophilia A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi (Taiwan), Sanofi Company.
Abstract (Originalsprache)
Sporadic hemophilia A (HA) enables the persistence of HA in the population. F8 gene inversion originates mainly in male germ cells during meiosis. To date, no studies have shown the origin and timing of HA sporadic noninversion variants (NIVs); herein, we assume that HA-sporadic NIVs are generated as a de novo variant. Of the 125 registered families with HA, 22 were eligible for inclusion. We conducted a linkage analysis using F8 gene markers and amplification refractory mutation system–quantitative polymerase chain reaction to confirm the origin of the sporadic NIVs (~0% mutant cells) or the presence of a mosaic variant, which requires further confirmation of the origin in the parent. Nine mothers, four maternal grandmothers, and six maternal grandfathers were confirmed to be the origin of sporadic NIVs, which most likely occurred in the zygote within the first few cell divisions and in single sperm cells, respectively. Three mothers had mosaic variants, which most likely occurred early in postzygotic embryogenesis. All maternal grandparents were free from sporadic NIV. In conclusion, F8 NIVs in sporadic HA were found to be caused primarily by de novo variants. Our studies are essential for understanding the genetic pathogenesis of HA and improving current genetic counseling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine, Changhua Christian Hospital, Changhua 500, Taiwan.
- Department of Obstetrics and Gynecology, Changhua Christian Hospital, Changhua 500, Taiwan.
- Department of Medical Genetics National Taiwan University Hospital, Taipei 100, Taiwan.
- Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei 100, Taiwan.
- Department of Laboratory Medicine, National Taiwan University Hospital, Taipei 100, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan.
ORCID-Profile: Ming Chen, Ming-Ching Shen, Gwo-Chin Ma
Förderung
- Sanofi (Taiwan)
- Sanofi Company
Zitieren
APA
Chen, M., Shen, M. C., Chang, S. P., Ma, G. C., Lee, D. J., & Yan, A. (2024). De Novo Noninversion Variants Implicated in Sporadic Hemophilia A: A Variant Origin and Timing Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031763
Vancouver
Chen M, Shen MC, Chang SP, Ma GC, Lee DJ, Yan A. De Novo Noninversion Variants Implicated in Sporadic Hemophilia A: A Variant Origin and Timing Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031763
BibTeX
@article{Chen2024,
author = {Chen, Ming and Shen, Ming-Ching and Chang, Shun-Ping and Ma, Gwo-Chin and Lee, Dong-Jay and Yan, Adeline},
title = {De Novo Noninversion Variants Implicated in Sporadic Hemophilia A: A Variant Origin and Timing Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031763}
}
EUVIMED